Reich K, Blauvelt A, Lebwohl M, Papp K, Rich P, Strober B, De Cuyper D, Madden C, Peterson L, Vanvoorden V, Warren R. Bimekizumab Safety in Patients with Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials. J of Skin [Internet]. 2021Jan.1 [cited 2024Jul.22];5(1):s21. Available from: https://jofskin.org/index.php/skin/article/view/1174